Remdesivir: Randomized Trial By Chinese Government Claims No Clinical Benefits - But Confounders Are Huge
A new paper claims that treatment with the antiviral drug remdesivir does not speed recovery from COVID-19 versus placebo in hospitalized patients who are critically ill.
But this needs to be…